| Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies L Marelli, R Stigliano, C Triantos, M Senzolo, E Cholongitas, N Davies, ... Cardiovascular and interventional radiology 30, 6-25, 2007 | 1056 | 2007 |
| Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy EA Tsochatzis, KS Gurusamy, S Ntaoula, E Cholongitas, BR Davidson, ... Journal of hepatology 54 (4), 650-659, 2011 | 884 | 2011 |
| Systematic review: the model for end‐stage liver disease–should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? E Cholongitas, GV Papatheodoridis, M Vangeli, N Terreni, D Patch, ... Alimentary pharmacology & therapeutics 22 (11‐12), 1079-1089, 2005 | 578 | 2005 |
| An appraisal of the histopathological assessment of liver fibrosis RA Standish, E Cholongitas, A Dhillon, AK Burroughs, AP Dhillon Gut 55 (4), 569-578, 2006 | 547 | 2006 |
| Transjugular liver biopsy–indications, adequacy, quality of specimens, and complications–a systematic review G Kalambokis, P Manousou, S Vibhakorn, L Marelli, E Cholongitas, ... Journal of hepatology 47 (2), 284-294, 2007 | 428 | 2007 |
| A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation E Cholongitas, L Marelli, V Shusang, M Senzolo, K Rolles, D Patch, ... Liver transplantation 12 (7), 1049-1061, 2006 | 377 | 2006 |
| Liver grafts from anti-hepatitis B core positive donors: a systematic review E Cholongitas, GV Papatheodoridis, AK Burroughs Journal of hepatology 52 (2), 272-279, 2010 | 342 | 2010 |
| A systematic review of the quality of liver biopsy specimens E Cholongitas, M Senzolo, R Standish, L Marelli, A Quaglia, D Patch, ... American journal of clinical pathology 125 (5), 710-721, 2006 | 330 | 2006 |
| Risk factors, sequential organ failure assessment and model for end‐stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive … E Cholongitas, M Senzolo, D Patch, K Kwong, V Nikolopoulou, G Leandro, ... Alimentary pharmacology & therapeutics 23 (7), 883-893, 2006 | 299 | 2006 |
| Discontinuation of oral antivirals in chronic hepatitis B: a systematic review G Papatheodoridis, I Vlachogiannakos, E Cholongitas, K Wursthorn, ... Hepatology 63 (5), 1481-1492, 2016 | 298 | 2016 |
| β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis M Senzolo, E Cholongitas, P Burra, G Leandro, U Thalheimer, D Patch, ... Liver International 29 (8), 1189-1193, 2009 | 293 | 2009 |
| The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related … VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ... Metabolism 71, 17-32, 2017 | 291 | 2017 |
| Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation M Senzolo, J Tibbals, E Cholongitas, CK Triantos, AK Burroughs, D Patch Alimentary pharmacology & therapeutics 23 (6), 767-775, 2006 | 269 | 2006 |
| New insights into the coagulopathy of liver disease and liver transplantation M Senzolo, P Burra, E Cholongitas, AK Burroughs World journal of gastroenterology: WJG 12 (48), 7725, 2006 | 246 | 2006 |
| Different methods of creatinine measurement significantly affect MELD scores E Cholongitas, L Marelli, A Kerry, M Senzolo, DW Goodier, D Nair, ... Liver Transplantation 13 (4), 523-529, 2007 | 212 | 2007 |
| Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation E Cholongitas, V Shusang, GV Papatheodoridis, L Marelli, P Manousou, ... Liver transplantation 14 (2), 138-143, 2008 | 200 | 2008 |
| renal function assessment in cirrhosis–difficulties and alternative measurements E Cholongitas, V Shusang, L Marelli, D Nair, M Thomas, D Patch, A Burns, ... Alimentary pharmacology & therapeutics 26 (7), 969-978, 2007 | 199 | 2007 |
| Scoring systems for assessing prognosis in critically ill adult cirrhotics E Cholongitas, M Senzolo, D Patch, S Shaw, C Hui, AK Burroughs Alimentary pharmacology & therapeutics 24 (3), 453-464, 2006 | 192 | 2006 |
| Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review E Cholongitas, C Mamou, KI Rodríguez‐Castro, P Burra Transplant International 27 (10), 1039-1049, 2014 | 191 | 2014 |
| Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts M Papatheodoridi, E Cholongitas Current pharmaceutical design 24 (38), 4574-4586, 2018 | 184 | 2018 |
George PapatheodoridisNational and Kapodistrian University of Athens, Medical School在 med.uoa.gr 的电子邮件经过验证
